Yaz/Yasmin/Ocella
Yaz Background:
Yaz is a form of birth control manufactured by Bayer. Yaz is an oral birth control pill taken once-a-day. It was originally approved by the FDA in March of 2006. In October of the same year it was approved for the treatment of Premenstrual Dysphoric Disorder (PMDD). In January of 2007, the FDA approved Yaz to treat moderate acne. Yaz contains ethinyl estradiol and drospirenone. The ethinyl estradiol affects the release of eggs, meanwhile the drospirenone interacts with the lining of the uterus. Of all of the available birth control pills only Yaz, Yasmin and Ocella contain drospirenone.
FDA Response:
Yaz was aggressively marketed to the public without adequate warnings. According to the FDA, the advertisements were misleading because they broaden the drug’s indication, overstate the efficacy of Yaz, and minimize serious risks associated with the use of the drug. The FDA concluded that the commercials encourage the use of the drug in circumstances other than those in which the drug has been approved, over-promise the benefits and minimize the risks associated with Yaz.
Yaz Problems:
You may have been harmed by Yaz if you have suffered the following:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Gallbladder Disease
- Pancreatitis
- Heart Attack
- Stroke
- Sudden Death
Yaz Litigation:
James, Vernon & Weeks, P.A. seeks to protect the rights of women who have been harmed by Yaz, Yasmin and Ocella. James, Vernon & Weeks, P.A. represents women suffering from Yaz, Yasmin and Ocella on a contingency basis. Contingency basis means that there are never any legal fees unless James, Vernon & Weeks, P.A. wins compensation in your case.
